Prev: Lithotripsy and radio opaque kidney stones
Next: GEMM Therapy
From: Marshall Price on 6 Apr 2008 18:25
ironjustice(a)aol.com wrote:
> On Apr 4, 4:24 pm, jay <jaym1...(a)hotmail.com> wrote: allergic to
> soybeans ,,
>
> You know there are alot of people allergic to peanut butter .. ? .. or
> peanuts .. ?
>
> Alot of people ..
>
> Thought you may like to know .. that ..
>
>
> Who loves ya.
> Tom
>
>
> Jesus Was A Vegetarian!
> http://tinyurl.com/2r2nkh
>
>
> Man Is A Herbivore!
> http://tinyurl.com/a3cc3
>
>
> DEAD PEOPLE WALKING
> http://tinyurl.com/zk9fk
>
>
>
>
>>> April 3, 2008 -- Intake of soy protein had beneficial effects ...
>> Implications of antinutritional components in soybean foods.Liener IE.
>> Department of Biochemistry, College of Biological Sciences, University
>> of Minnesota, St. Paul 55108-1022.
>>
>> There are a number of components present in soybeans that exert a
>> negative impact on the nutritional quality of the protein. Among those
>> factors that are destroyed by heat treatment are the protease
>> inhibitors and lectins. Protease inhibitors exert their
>> antinutritional effect by causing pancreatic hypertrophy/hyperplasia,
>> which ultimately results in an inhibition of growth. The lectin, by
>> virtue of its ability to bind to glycoprotein receptors on the
>> epithelial cells lining the intestinal mucosa, inhibits growth by
>> interfering with the absorption of nutrients. Of lesser significance
>> are the antinutritional effects produced by relatively heat stable
>> factors, such as goitrogens, tannins, phytoestrogens, flatus-producing
>> oligosaccharides, phytate, and saponins. Other diverse but ill-defined
>> factors appear to increase the requirements for vitamins A, B12, D,
>> and E. The processing of soybeans under severe alkaline conditions
>> leads to the formation of lysinoalanine, which has been shown to
>> damage the kidneys of rats. This is not generally true, however, for
>> edible soy protein that has been produced under milder alkaline
>> conditions. Also meriting consideration is the allergenic response
>> that may sometimes occur in humans, as well as calves and piglets, on
>> dietary exposure to soybeans.
>>
>> PMID: 8142044


I can't figure out who (Tom or Jay) said "Alot of people," but if you're
going to cross-post in sci.med and sci.med.nutrition, you might (1) look
up and tell us the actual incidence, (2) distinguish between conflicting
definitions of "allergy" with respect to foods, (3) mention aflatoxins
and their significance to peanut consumption, and (4) put it in a thread
on peanut consumption generally, not *soybeans* in the diets of patients
with *DM2-associated nephropathy*. Right?


--
Marshall Price of Miami
Known to Yahoo as d021317c
From: ironjustice on 7 Apr 2008 00:05
On Apr 6, 3:06 pm, Marshall Price <d0213...(a)yahoo.com> wrote:I don't
get it. What were the experimenters' conclusions? <<

I'll give you a tip ..

Article reading .. 101 ..

Usually the conclusion is found at the bottom of the article ..

"The current study finds that a soy protein diet can reduce levels of
fasting plasma glucose, cholesterol, and CRP and decrease proteinuria
vs a control diet among patients with type 2 diabetes and
nephropathy.
However, body weight was similar between the 2 groups."

Now if you don't understand the short little four line paragraph
above .. buddy .. you are .. S=O=L ..

Just kidding .. Marshall ..

It says .. "soy protein diet good" ..

I'll .. assume you know the study was done in those with ..
nephropathy and type 2 diabetes.

Nephropathy is .. kidney disease ..

Who loves ya.
Tom


Jesus Was A Vegetarian!
http://tinyurl.com/2r2nkh


Man Is A Herbivore!
http://tinyurl.com/a3cc3


DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk




>
> I don't get it. What were the experimenters' conclusions?

> spam.st...(a)yahoo.fr wrote:
>
> > ironjustice wrote:
> >>http://www.medscape.com/viewarticle/572440
>
> >> April 3, 2008 -- Intake of soy protein had beneficial effects on
> >> cardiovascular risk factors and kidney-related biomarkers in patients
> >> with type 2 diabetes and nephropathy, according to the results of a
> >> longitudinal, randomized trial published in the April issue of
> >> Diabetes Care.
>
> >> "Several short-term trials on the effect of soy consumption on
> >> cardiovascular risks are available, but little evidence exists
> >> regarding the impact of long-term soy protein consumption among type 2
> >> diabetic patients with nephropathy," write Leila Azadbakht, PhD, from
> >> the Isfahan University of Medical Sciences in Isfahan, Iran, and
> >> colleagues. "To determine the effects of long-term soy consumption on
> >> cardiovascular risks, we measured C-reactive protein (CRP) and kidney
> >> function indexes among type 2 diabetic patients with nephropathy."
>
> >> Of 41 patients with type 2 diabetes and nephropathy who were enrolled
> >> in this study, 18 were men and 23 were women. The soy protein group (n
> >> = 20) was assigned to a diet containing 0.8 g protein/kg body weight
> >> (35% animal proteins, 35% textured soy protein, and 30% vegetable
> >> proteins), whereas the control group
> >> (n = 21) was assigned to a similar diet containing 70% animal proteins
> >> and 30% vegetable proteins. Duration of the study was 4 years.
>
> >> The soy protein group fared better than the control group regarding
> >> effects on cardiovascular risk factors. Mean change in the soy protein
> >> vs control groups for fasting plasma glucose levels was
> >> -18 � 3 vs 11 � 2 mg/dL (P = .03); for total cholesterol levels,
> >> -23 � 5 vs 10 � 3 mg/dL (P =.01); for low-density lipoprotein (LDL)
> >> cholesterol levels, -20 � 5 vs 6 � 2 mg/dL (P = .01); and for serum
> >> triglyceride levels, -24 � 6 vs -5 � 2 mg/dL (P = .01).
>
> >> Compared with the control group, the soy protein group also had
> >> greater decreases in serum CRP levels (1.31 � 0.6 vs 0.33 � 0.1 mg/L;
> >> P = .02) and significant reductions in proteinuria (-0.15 � 0..03 vs
> >> 0.02 � 0.01 g/day;
> >> P = .001) and urinary creatinine levels (-1.5 � 0.9 vs 0.6 � 0.3 mg/
> >> dL; P = .01).
>
> >> Limitations of the study include evaluation of only CRP rather than
> >> other inflammatory markers, evaluation of only a single dosage range
> >> and formulation of soy protein, lack of data on the effects of soy
> >> protein according to estrogen receptor genotype, and measurement of
> >> urinary urea nitrogen and urinary creatinine as concentrations rather
> >> than as 24-hour excretions.
>
> >> "Longitudinal soy protein consumption significantly affected
> >> cardiovascular risk factors and kidney-related biomarkers among type 2
> >> diabetic patients with nephropathy," the study authors write. "As
> >> diabetic nephropathy is a progressive disease, we expected that the
> >> conditions of these patients would have gotten worse after 4 years,
> >> but because of medical and dietary control, their conditions improved
> >> in some respects."
>
> >> The costs of publication of this article were defrayed in part by the
> >> payment of page charges, mandating that it must therefore be hereby
> >> marked "advertisement" solely to indicate this fact.
>
> >> Diabetes Care. 2008;31:648-654.
>
> >> Clinical Context
> >> Diet is a cornerstone of the management of diabetes, and the authors
> >> of the current study previously demonstrated that the inclusion of soy
> >> and vegetable protein can improve laboratory variables in the short
> >> term among patients with diabetes. They performed a crossover clinical
> >> trial among 14 patients with diabetes and nephropathy, which was
> >> published in the October 2003 issue of the European Journal of
> >> Clinical Nutrition. In this study, the use of a diet in which 35% of
> >> the protein was derived from soy and another 30% from vegetable
> >> sources improved levels of total cholesterol, triglycerides, and LDL
> >> cholesterol after 7 weeks. The soy and vegetable protein diet also
> >> reduced proteinuria but did not affect levels of high-density
> >> lipoprotein (HDL) cholesterol.
>
> >> The current study observes a larger patient cohort for a longer period
> >> to determine the significance of a soy protein diet among patients
> >> with type 2 diabetes and nephropathy.
>
> >> Study Highlights
> >> Participants in the current study had type 2 diabetes and proteinuria,
> >> with a total urinary protein excretion between 300 and 1000 mg/day.
> >> Participants' serum creatinine level was between 1 and 2.5 mg/dL, and
> >> the serum urea nitrogen level was between 20 and 40 mg/dL. Subjects'
> >> systolic and diastolic blood pressure was greater than 140 and 90 mm
> >> Hg, respectively.
> >> Subjects were randomized to a control diet consisting of 0.8 g protein/
> >> kg body weight, with 70% animal protein and 30% vegetable protein; or
> >> a soy protein group consisting of 0.8 g protein/kg body weight, with
> >> 35% animal protein, 35% soy protein, and 30% vegetable proteins.
> >> Participants received visits with a dietician to encourage adherence
> >> to their randomized diet.
> >> The outcomes of the study were renal function, degree of proteinuria,
> >> serum lipid levels, and CRP levels. These outcomes were assessed every
> >> 6 months for 4 years.
> >> 41 participants provided data for analysis. 43% of subjects were men,
> >> and the mean age of subjects was 62.1 years. The mean duration of
> >> diabetes was 10 years, and the mean glycated hemoglobin level was
> >> 6.2%.
> >> There was no difference in total mean energy intake or activity levels
> >> between groups during the trial.
> >> Mean body weight was similar between diet groups at 4 years.
> >> Mean fasting plasma glucose levels decreased by 18 mg/dL in the soy
> >> protein diet group but increased by 11 mg/dL in the control group,
> >> which is a significant difference.
> >> Total cholesterol levels decreased by 23 mg/dL in the soy protein diet
> >> group and increased by 5 mg/dL in the control group, which was also
> >> statistically significant. LDL cholesterol and triglyceride levels
> >> also were reduced more significantly in the soy protein vs the control
> >> diet groups. HDL cholesterol levels were similar in both groups.
> >> CRP levels decreased by 1.31 in the soy protein diet group and 0.33 in
> >> the control group, which is a significant difference.
> >> Proteinuria decreased slightly in the soy protein diet group and
> >> increased slightly in the control group, and this difference was also
> >> statistically significant.
> >> Urinary urea nitrogen and urinary creatinine levels were improved in
> >> the soy protein vs control diet groups, but serum creatinine and serum
> >> urea nitrogen levels and the glomerular filtration rate were similar
> >> at 4 years between groups.
> >> The favorable effects of the soy protein diet on proteinuria were
> >> independent of its effects on plasma glucose, but not lipid, levels.
> >> Pearls for Practice
> >> A small trial of a soy-based and vegetable-based protein diet among
> >> patients with diabetes and nephropathy demonstrated that this diet
> >> could reduce levels of total cholesterol, triglycerides, and LDL
> >> cholesterol and decrease proteinuria in the short term.
> >> The current study finds that a soy protein diet can reduce levels of
> >> fasting plasma glucose, cholesterol, and CRP and decrease proteinuria
> >> vs a control diet among patients with type 2 diabetes and nephropathy.
> >> However, body weight was similar between the 2 groups.
>
> I don't get it.  What were the experimenters' conclusions?
>
> --
> Marshall Price of Miami
> Known to Yahoo as d021317c- Hide quoted text -
>
> - Show quoted text -

From: ironjustice on 13 Apr 2008 11:37
On Apr 4, 8:01 am, ironjustice <teamtan...(a)hotmail.com> wrote:Soybean
<<

Scientists Identify Key Lipid-Lowering Ingredient in Soybeans
June 2004
It has been known for years that the consumption of soybeans improves
cardiovascular health by helping to remove LDL (bad) cholesterol from
the blood stream. An intensive search has been underway for the active
agent in soybeans responsible for this benefit, in the hope that it
might prove useful as a nutraceutical or dietary supplement. A team of
Italian scientists has now identified the active protein molecule in
soybeans that lowers blood lipid levels and have labeled it the alpha-
prime subunit of the soybean 7S globulin. (A globulin is a polypeptide
chain that is folded like a globe, and is water insoluble). They also
have discovered the mechanism through which it accomplishes this
beneficial outcome.

This alpha-prime polypeptide subunit is one of three that make up the
soybean 7S globulin. It constitutes about 35 percent of the 7S
globulin. It works by upregulating the Beta-VLDL receptor in the
liver, in effect stimulating the liver to more aggressively latch onto
and metabolize LDL cholesterol in the blood supply. The authors
highlight one aspect of their findings -

"The results of the present study, in our opinion, are extremely
intriguing because they show for the first time that a dietary protein
is active at concentrations that are lower than those reported for
hypolipidemic drugs."

Given that this biologically active protein has just been isolated, no
work has been done on the impact of genetics and farming systems on
its levels in soybeans, nor on the impact of food processing and food
preparation. The Organic Center will continue to monitor research in
this area to see if there are ways to increase the concentration of
this key protein.

Source: "The Alpha-Prime Subunit from Soybean 7S Globulin Lowers
Plasma Lipids and Upregulates Liver Beta-VLDL Receptors in Rats Fed a
Hypercholesterolemic Diet"

Authors: Marcello Duranti, Maria Rosa Lovati, Valeria Dani, Alberto
Barbiroli, Alessio Scarafoni, Silvia Castiglioni, Cesare Ponzone, and
Paolo Morazzoni, University of Milan, Italy

Journal: The Journal of Nutrition, Volume 134, No. 6, June 2004


Who loves ya.
Tom


Jesus Was A Vegetarian!
http://tinyurl.com/2r2nkh


Man Is A Herbivore!
http://tinyurl.com/a3cc3


DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk





> http://www.medscape.com/viewarticle/572440
>
> April 3, 2008 -- Intake of soy protein had beneficial effects on
> cardiovascular risk factors and kidney-related biomarkers in patients
> with type 2 diabetes and nephropathy, according to the results of a
> longitudinal, randomized trial published in the April issue of
> Diabetes Care.
>
> "Several short-term trials on the effect of soy consumption on
> cardiovascular risks are available, but little evidence exists
> regarding the impact of long-term soy protein consumption among type 2
> diabetic patients with nephropathy," write Leila Azadbakht, PhD, from
> the Isfahan University of Medical Sciences in Isfahan, Iran, and
> colleagues. "To determine the effects of long-term soy consumption on
> cardiovascular risks, we measured C-reactive protein (CRP) and kidney
> function indexes among type 2 diabetic patients with nephropathy."
>
> Of 41 patients with type 2 diabetes and nephropathy who were enrolled
> in this study, 18 were men and 23 were women. The soy protein group (n
> = 20) was assigned to a diet containing 0.8 g protein/kg body weight
> (35% animal proteins, 35% textured soy protein, and 30% vegetable
> proteins), whereas the control group
> (n = 21) was assigned to a similar diet containing 70% animal proteins
> and 30% vegetable proteins. Duration of the study was 4 years.
>
> The soy protein group fared better than the control group regarding
> effects on cardiovascular risk factors. Mean change in the soy protein
> vs control groups for fasting plasma glucose levels was
> -18 ± 3 vs 11 ± 2 mg/dL (P = .03); for total cholesterol levels,
> -23 ± 5 vs 10 ± 3 mg/dL (P =.01); for low-density lipoprotein (LDL)
> cholesterol levels, -20 ± 5 vs 6 ± 2 mg/dL (P = .01); and for serum
> triglyceride levels, -24 ± 6 vs -5 ± 2 mg/dL (P = .01).
>
> Compared with the control group, the soy protein group also had
> greater decreases in serum CRP levels (1.31 ± 0.6 vs 0.33 ± 0.1 mg/L;
> P = .02) and significant reductions in proteinuria (-0.15 ± 0.03 vs
> 0.02 ± 0.01 g/day;
> P = .001) and urinary creatinine levels (-1.5 ± 0.9 vs 0.6 ± 0.3 mg/
> dL; P = .01).
>
> Limitations of the study include evaluation of only CRP rather than
> other inflammatory markers, evaluation of only a single dosage range
> and formulation of soy protein, lack of data on the effects of soy
> protein according to estrogen receptor genotype, and measurement of
> urinary urea nitrogen and urinary creatinine as concentrations rather
> than as 24-hour excretions.
>
> "Longitudinal soy protein consumption significantly affected
> cardiovascular risk factors and kidney-related biomarkers among type 2
> diabetic patients with nephropathy," the study authors write. "As
> diabetic nephropathy is a progressive disease, we expected that the
> conditions of these patients would have gotten worse after 4 years,
> but because of medical and dietary control, their conditions improved
> in some respects."
>
> The costs of publication of this article were defrayed in part by the
> payment of page charges, mandating that it must therefore be hereby
> marked "advertisement" solely to indicate this fact.
>
> Diabetes Care. 2008;31:648-654.
>
> Clinical Context
> Diet is a cornerstone of the management of diabetes, and the authors
> of the current study previously demonstrated that the inclusion of soy
> and vegetable protein can improve laboratory variables in the short
> term among patients with diabetes. They performed a crossover clinical
> trial among 14 patients with diabetes and nephropathy, which was
> published in the October 2003 issue of the European Journal of
> Clinical Nutrition. In this study, the use of a diet in which 35% of
> the protein was derived from soy and another 30% from vegetable
> sources improved levels of total cholesterol, triglycerides, and LDL
> cholesterol after 7 weeks. The soy and vegetable protein diet also
> reduced proteinuria but did not affect levels of high-density
> lipoprotein (HDL) cholesterol.
>
> The current study observes a larger patient cohort for a longer period
> to determine the significance of a soy protein diet among patients
> with type 2 diabetes and nephropathy.
>
> Study Highlights
> Participants in the current study had type 2 diabetes and proteinuria,
> with a total urinary protein excretion between 300 and 1000 mg/day.
> Participants' serum creatinine level was between 1 and 2.5 mg/dL, and
> the serum urea nitrogen level was between 20 and 40 mg/dL. Subjects'
> systolic and diastolic blood pressure was greater than 140 and 90 mm
> Hg, respectively.
> Subjects were randomized to a control diet consisting of 0.8 g protein/
> kg body weight, with 70% animal protein and 30% vegetable protein; or
> a soy protein group consisting of 0.8 g protein/kg body weight, with
> 35% animal protein, 35% soy protein, and 30% vegetable proteins.
> Participants received visits with a dietician to encourage adherence
> to their randomized diet.
> The outcomes of the study were renal function, degree of proteinuria,
> serum lipid levels, and CRP levels. These outcomes were assessed every
> 6 months for 4 years.
> 41 participants provided data for analysis. 43% of subjects were men,
> and the mean age of subjects was 62.1 years. The mean duration of
> diabetes was 10 years, and the mean glycated hemoglobin level was
> 6.2%.
> There was no difference in total mean energy intake or activity levels
> between groups during the trial.
> Mean body weight was similar between diet groups at 4 years.
> Mean fasting plasma glucose levels decreased by 18 mg/dL in the soy
> protein diet group but increased by 11 mg/dL in the control group,
> which is a significant difference.
> Total cholesterol levels decreased by 23 mg/dL in the soy protein diet
> group and increased by 5 mg/dL in the control group, which was also
> statistically significant. LDL cholesterol and triglyceride levels
> also were reduced more significantly in the soy protein vs the control
> diet groups. HDL cholesterol levels were similar in both groups.
> CRP levels decreased by 1.31 in the soy protein diet group and 0.33 in
> the control group, which is a significant difference.
> Proteinuria decreased slightly in the soy protein diet group and
> increased slightly in the control group, and this difference was also
> statistically significant.
> Urinary urea nitrogen and urinary creatinine levels were improved in
> the soy protein vs control diet groups, but serum creatinine and serum
> urea nitrogen levels and the glomerular filtration rate were similar
> at 4 years between groups.
> The favorable effects of the soy protein diet on proteinuria were
> independent of its effects on plasma glucose, but not lipid, levels.
> Pearls for Practice
> A small trial of a soy-based and vegetable-based protein diet among
> patients with diabetes and nephropathy demonstrated that this diet
> could reduce levels of total cholesterol, triglycerides, and LDL
> cholesterol and decrease proteinuria in the short term.
> The current study finds that a soy protein diet can reduce levels of
> fasting plasma glucose, cholesterol, and CRP and decrease proteinuria
> vs a control diet among patients with type 2 diabetes and nephropathy.
> However, body weight was similar between the 2 groups.
>
> Who loves ya.
> Tom
>
> Jesus Was A Vegetarian!http://tinyurl.com/2r2nkh
>
> Man Is A Herbivore!http://tinyurl.com/a3cc3
>
> DEAD PEOPLE WALKINGhttp://tinyurl.com/zk9fk

From: ironjustice on 16 Apr 2008 00:25
On Apr 4, 4:37 pm, "ironjust...(a)aol.com" <ironjust...(a)aol.com>
wrote:allergic to
soybeans <<

http://tinyurl.com/3u8a49

Soy Lecithin Unfairly Characterized As An Allergen

There certainly are a lot of challenges facing the dietary supplement
industry these days. The industry has its own set of self-induced
problems delivering products that don't match label claims. A visit to
www.ConsumerLab.com provides continued evidence of this.

Then there are the challenges posed from outside the industry. The
production of pseudoscience, to scare the public away from dietary
supplements, is now a monthly occurrence. False science has been
created to say vitamin E increases the risk of heart failure, high-
dose vitamin C is worthless and could cause genetic mutations, vitamin
D could cause calcifications, beta carotene induces lung cancer in
smokers.

Then there is adverse event reporting, the proposed idea of mandating
every dietary supplement company keep records of every adverse event
reported by consumers. (This is going to be a field day for lawyers,
who will file suits, and under legal discovery, be able to mine all
the adverse event files of every supplement company to extort payments
from them, regardless of whether the supplements were the cause of
adverse events or not.)

Then there is CODEX, the authoritarian regulations that will soon
"harmonize" dietary supplements into pablum doses that do little to
prevent disease and certainly pose no threat to the pharmaceutical
industry.

But none of these yet pose the threat to dietary supplements as the
Food Allergy Labeling Consumer Protection Act of 2004. As of January
2006 all new dietary supplements that contain common allergens must be
labeled so that allergen-sensitive individuals, estimated at 2% of the
population, can avoid products that may trigger reactions. Because of
the threat of aflatoxin (a toxic mold), this includes "products that
contain nuts, or products made in factories where nuts were processed,
or any soy products"....stop right there --- this means products that
contain soy lecithin must be identified as an "allergen."

How does the public perceive this? One company added lecithin to a
dietary supplement and had to disclose it "contains soy." Hundreds of
consumers called to complain. Forget the fact they eat lecithin in
candy bars, baked goods and beverages every day, what is it doing in
their food supplement?!! Why, toxic soy is an allergen, so lecithin
must be too! Overlook the fact that lecithin is phosphatidylcholine,
which is found in every cell of the human body. Also, disregard
scientific studies which show that proteins in soy lecithin have
little ability to create antigens (allergy-provoking agents) even
among those who are allergic to soybeans. [Clinical Experimental
Allergy 28: 1559-64, 1998]

The soy bashers have been very active. According to a report in Nexus
magazine, soy is one of the top allergens (yes, along with fish, eggs,
milk, peanuts, wheat, you know, regular foods that are promoted in the
government Food Pyramid), and is one of the "sinister seven" foods
that can cause an immediate hypersensitivity reaction. Soy is not just
a food that sensitive individuals should be aware of, it has now been
misconstrued to cause life-threatening allergies in 98 percent of the
public that aren't allergy sensitive.

Widely quoted is a report from Sweden, that six allergy-sensitive
children died after eating soy foods. [Allergy 54: 261, 1999] These
deaths were reported over a 5-year period (1992-96). In the most
recent 7-year period, soy-related allergic deaths in Sweden have
dropped to just one-life threatening case (subject didn't die).
[Lakartidningen 102: 3465-68, 2005] Forget the facts, what the public
hears is that soy kills!

What people are told is that your kids could be eating a soy burger in
the school lunchroom, and their parents could visit their body in the
morgue an hour later. Here is what one child allergy resource on the
internet says: "Children with a true soy allergy can experience
potentially life-threatening conditions such as anaphylactic shock,
and those with soy allergies should avoid all foods that contain soy.
Should a child with soy allergies ingest soy, they'll need immediate
medical attention."

Furthermore, according to the Food Allergen Labeling and Consumer
Protection Act of 2004, "The burden shall be on any petitioner to
provide scientific evidence that such food ingredient does not cause
an allergenic response that poses a risk to human health." Soy
lecithin is guilty until proven innocent. According to a recent
survey, 38% of parents of allergy-sensitive children avoided products
with soy lecithin, just to be on the safe side. [Annals Allergy Asthma
Immunology 95: 426-28, 2005]

Folks, advocates and devotees of dietary supplements, makers of
lecithin products cannot bear the burden of answering endless phone
calls from nutriphobic consumers. Forget that more people die from
aspirin or acetaminophen, commonly used over-the-counter pain
relievers, or die from side reactions to drugs that doctors prescribe,
a major dietary supplement, lecithin, is now a major allergen, and a
child killer! Every precaution must be taken, with no regard to
expense, to protect that one allergy-sensitive child from dying.

Now, just published is a report showing life-threatening anaphylactic
reactions can occur from grapes and wine. [Allergy Asthma Proceedings
26: 53-58, 2005] Soon wine bottles will be labeled as potential
allergens. So will grape seed extract and resveratrol pills in food
supplements.

Not to worry about CODEX. It is nutriphobic consumers themselves who
will destroy the dietary supplement industry.

- Copyright 2006 Bill Sardi, Knowledge of Health, Inc.


Who loves ya.
Tom


Jesus Was A Vegetarian!
http://tinyurl.com/2r2nkh


Man Is A Herbivore!
http://tinyurl.com/a3cc3


DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk





> On Apr 4, 4:24 pm, jay <jaym1...(a)hotmail.com> wrote: allergic to
> soybeans ,,
>
> You know there are alot of people allergic to peanut butter .. ? .. or
> peanuts .. ?
>
> Alot of people ..
>
> Thought you may like to know .. that ..
>
> Who loves ya.
> Tom
>
> Jesus Was A Vegetarian!http://tinyurl.com/2r2nkh
>
> Man Is A Herbivore!http://tinyurl.com/a3cc3
>
> DEAD PEOPLE WALKINGhttp://tinyurl.com/zk9fk
>
>
>
> > > April 3, 2008 -- Intake ofsoyprotein had beneficial effects ...
>
> > Implications of antinutritional components in soybean foods.Liener IE.
> > Department of Biochemistry, College of Biological Sciences, University
> > of Minnesota, St. Paul 55108-1022.
>
> > There are a number of components present in soybeans that exert a
> > negative impact on the nutritional quality of the protein. Among those
> > factors that are destroyed by heat treatment are the protease
> > inhibitors and lectins. Protease inhibitors exert their
> > antinutritional effect by causing pancreatic hypertrophy/hyperplasia,
> > which ultimately results in an inhibition of growth. The lectin, by
> > virtue of its ability to bind to glycoprotein receptors on the
> > epithelial cells lining the intestinal mucosa, inhibits growth by
> > interfering with the absorption of nutrients. Of lesser significance
> > are the antinutritional effects produced by relatively heat stable
> > factors, such as goitrogens, tannins, phytoestrogens, flatus-producing
> > oligosaccharides, phytate, and saponins. Other diverse but ill-defined
> > factors appear to increase the requirements for vitamins A, B12, D,
> > and E. The processing of soybeans under severe alkaline conditions
> > leads to the formation of lysinoalanine, which has been shown to
> > damage the kidneys of rats. This is not generally true, however, for
> > ediblesoyprotein that has been produced under milder alkaline
> > conditions. Also meriting consideration is the allergenic response
> > that may sometimes occur in humans, as well as calves and piglets, on
> > dietary exposure to soybeans.
>
> > PMID: 8142044- Hide quoted text -
>
> - Show quoted text -

From: trigonometry1972 on 16 Apr 2008 07:17
On Apr 6, 9:05 pm, ironjustice <teamtan...(a)hotmail.com> wrote:
> On Apr 6, 3:06 pm, Marshall Price <d0213...(a)yahoo.com> wrote:I don't
> get it.  What were the experimenters' conclusions? <<
>
> I'll give you a tip ..
>
> Article reading .. 101 ..
>
> Usually the conclusion is found at the bottom of the article ..
>
> "The current study finds that a soy protein diet can reduce levels of
>  fasting plasma glucose, cholesterol, and CRP and decrease proteinuria
>  vs a control diet among patients with type 2 diabetes and
> nephropathy.
>  However, body weight was similar between the 2 groups."
>
> Now if you don't understand the short little four line paragraph
> above .. buddy .. you are .. S=O=L ..
>
> Just kidding .. Marshall ..
>
> It says .. "soy protein diet good" ..
>
> I'll .. assume you know the study was done in those with ..
> nephropathy and type 2 diabetes.
>
> Nephropathy is .. kidney disease ..
>
> Who loves ya.
> Tom
>
> Jesus Was A Vegetarian!http://tinyurl.com/2r2nkh
>
> Man Is A Herbivore!http://tinyurl.com/a3cc3
>
> DEAD PEOPLE WALKINGhttp://tinyurl.com/zk9fk
>
>
>
> > I don't get it.  What were the experimenters' conclusions?
> > spam.st...(a)yahoo.fr wrote:
>
> > > ironjustice wrote:
> > >>http://www.medscape.com/viewarticle/572440
>
> > >> April 3, 2008 -- Intake of soy protein had beneficial effects on
> > >> cardiovascular risk factors and kidney-related biomarkers in patients
> > >> with type 2 diabetes and nephropathy, according to the results of a
> > >> longitudinal, randomized trial published in the April issue of
> > >> Diabetes Care.
>
> > >> "Several short-term trials on the effect of soy consumption on
> > >> cardiovascular risks are available, but little evidence exists
> > >> regarding the impact of long-term soy protein consumption among type 2
> > >> diabetic patients with nephropathy," write Leila Azadbakht, PhD, from
> > >> the Isfahan University of Medical Sciences in Isfahan, Iran, and
> > >> colleagues. "To determine the effects of long-term soy consumption on
> > >> cardiovascular risks, we measured C-reactive protein (CRP) and kidney
> > >> function indexes among type 2 diabetic patients with nephropathy."
>
> > >> Of 41 patients with type 2 diabetes and nephropathy who were enrolled
> > >> in this study, 18 were men and 23 were women. The soy protein group (n
> > >> = 20) was assigned to a diet containing 0.8 g protein/kg body weight
> > >> (35% animal proteins, 35% textured soy protein, and 30% vegetable
> > >> proteins), whereas the control group
> > >> (n = 21) was assigned to a similar diet containing 70% animal proteins
> > >> and 30% vegetable proteins. Duration of the study was 4 years.
>
> > >> The soy protein group fared better than the control group regarding
> > >> effects on cardiovascular risk factors. Mean change in the soy protein
> > >> vs control groups for fasting plasma glucose levels was
> > >> -18 � 3 vs 11 � 2 mg/dL (P = .03); for total cholesterol levels,
> > >> -23 � 5 vs 10 � 3 mg/dL (P =.01); for low-density lipoprotein (LDL)
> > >> cholesterol levels, -20 � 5 vs 6 � 2 mg/dL (P = .01); and for serum
> > >> triglyceride levels, -24 � 6 vs -5 � 2 mg/dL (P = .01).
>
> > >> Compared with the control group, the soy protein group also had
> > >> greater decreases in serum CRP levels (1.31 � 0.6 vs 0.33 � 0.1 mg/L;
> > >> P = .02) and significant reductions in proteinuria (-0.15 � 0.03 vs
> > >> 0.02 � 0.01 g/day;
> > >> P = .001) and urinary creatinine levels (-1.5 � 0.9 vs 0.6 � 0.3 mg/
> > >> dL; P = .01).
>
> > >> Limitations of the study include evaluation of only CRP rather than
> > >> other inflammatory markers, evaluation of only a single dosage range
> > >> and formulation of soy protein, lack of data on the effects of soy
> > >> protein according to estrogen receptor genotype, and measurement of
> > >> urinary urea nitrogen and urinary creatinine as concentrations rather
> > >> than as 24-hour excretions.
>
> > >> "Longitudinal soy protein consumption significantly affected
> > >> cardiovascular risk factors and kidney-related biomarkers among type 2
> > >> diabetic patients with nephropathy," the study authors write. "As
> > >> diabetic nephropathy is a progressive disease, we expected that the
> > >> conditions of these patients would have gotten worse after 4 years,
> > >> but because of medical and dietary control, their conditions improved
> > >> in some respects."
>
> > >> The costs of publication of this article were defrayed in part by the
> > >> payment of page charges, mandating that it must therefore be hereby
> > >> marked "advertisement" solely to indicate this fact.
>
> > >> Diabetes Care. 2008;31:648-654.
>
> > >> Clinical Context
> > >> Diet is a cornerstone of the management of diabetes, and the authors
> > >> of the current study previously demonstrated that the inclusion of soy
> > >> and vegetable protein can improve laboratory variables in the short
> > >> term among patients with diabetes. They performed a crossover clinical
> > >> trial among 14 patients with diabetes and nephropathy, which was
> > >> published in the October 2003 issue of the European Journal of
> > >> Clinical Nutrition. In this study, the use of a diet in which 35% of
> > >> the protein was derived from soy and another 30% from vegetable
> > >> sources improved levels of total cholesterol, triglycerides, and LDL
> > >> cholesterol after 7 weeks. The soy and vegetable protein diet also
> > >> reduced proteinuria but did not affect levels of high-density
> > >> lipoprotein (HDL) cholesterol.
>
> > >> The current study observes a larger patient cohort for a longer period
> > >> to determine the significance of a soy protein diet among patients
> > >> with type 2 diabetes and nephropathy.
>
> > >> Study Highlights
> > >> Participants in the current study had type 2 diabetes and proteinuria,
> > >> with a total urinary protein excretion between 300 and 1000 mg/day.
> > >> Participants' serum creatinine level was between 1 and 2.5 mg/dL, and
> > >> the serum urea nitrogen level was between 20 and 40 mg/dL. Subjects'
> > >> systolic and diastolic blood pressure was greater than 140 and 90 mm
> > >> Hg, respectively.
> > >> Subjects were randomized to a control diet consisting of 0.8 g protein/
> > >> kg body weight, with 70% animal protein and 30% vegetable protein; or
> > >> a soy protein group consisting of 0.8 g protein/kg body weight, with
> > >> 35% animal protein, 35% soy protein, and 30% vegetable proteins.
> > >> Participants received visits with a dietician to encourage adherence
> > >> to their randomized diet.
> > >> The outcomes of the study were renal function, degree of proteinuria,
> > >> serum lipid levels, and CRP levels. These outcomes were assessed every
> > >> 6 months for 4 years.
> > >> 41 participants provided data for analysis. 43% of subjects were men,
> > >> and the mean age of subjects was 62.1 years. The mean duration of
> > >> diabetes was 10 years, and the mean glycated hemoglobin level was
> > >> 6.2%.
> > >> There was no difference in total mean energy intake or activity levels
> > >> between groups during the trial.
> > >> Mean body weight was similar between diet groups at 4 years.
> > >> Mean fasting plasma glucose levels decreased by 18 mg/dL in the soy
> > >> protein diet group but increased by 11 mg/dL in the control group,
> > >> which is a significant difference.
> > >> Total cholesterol levels decreased by 23 mg/dL in the soy protein diet
> > >> group and increased by 5 mg/dL in the control group, which was also
> > >> statistically significant. LDL cholesterol and triglyceride levels
> > >> also were reduced more significantly in the soy protein vs the control
> > >> diet groups. HDL cholesterol levels were similar in both groups.
> > >> CRP levels decreased by 1.31 in the soy protein diet group and 0.33 in
> > >> the control group, which is a significant difference.
> > >> Proteinuria decreased slightly in the soy protein diet group and
> > >> increased slightly in the control group, and this difference was also
> > >> statistically significant.
> > >> Urinary urea nitrogen and urinary creatinine levels were improved in
> > >> the soy protein vs control diet groups, but serum creatinine and serum
> > >> urea nitrogen levels and the glomerular filtration rate were similar
> > >> at 4 years between groups.
> > >> The favorable effects of the soy protein diet on proteinuria were
> > >> independent of its effects on plasma glucose, but not lipid, levels.
> > >> Pearls for Practice
> > >> A small trial of a soy-based and vegetable-based protein diet among
> > >> patients with diabetes and nephropathy demonstrated that this diet
> > >> could reduce levels of total cholesterol, triglycerides, and LDL
> > >> cholesterol and decrease proteinuria in the short term.
> > >> The current study finds that a soy protein diet can reduce levels of
> > >> fasting plasma glucose, cholesterol, and CRP and decrease proteinuria
> > >> vs a control diet among patients with type 2 diabetes and nephropathy..
> > >> However, body weight was similar between the 2 groups.
>
> > I don't get it.  What were the experimenters' conclusions?
>
> > --
> > Marshall Price of Miami
> > Known to Yahoo as d021317c- Hide quoted text -
>
> > - Show quoted text -

Old ironinjustice is nothing if nor smug.

Who does he love? No one other than
himself and then that is even in question.

Back to the topic.
The question I wonder is about is the nature
of the control diet. Was it a SAD (standard
American diet)? It doesn't take much to
improve on SAD. Better competation to
a soy diet would be low carb diet based
on low carb veggies, certain nuts and specific seeds,
red meat, and cold water oceanic wild caught fish, plus a little
diary.

For Tom.
Jesus loved roasted lamb with bitter herbs.
First  |  Prev  |  Next  |  Last
Pages: 1 2 3 4
Prev: Lithotripsy and radio opaque kidney stones
Next: GEMM Therapy